These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26811629)

  • 21. STAT5A Modulates Chemokine Receptor CCR6 Expression and Enhances Pre-B Cell Growth in a CCL20-Dependent Manner.
    Tsuruyama T; Hiratsuka T; Aini W; Nakamura T
    J Cell Biochem; 2016 Nov; 117(11):2630-42. PubMed ID: 27018255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
    Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
    PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine receptors in the pathogenesis and therapy of psoriasis.
    Mabuchi T; Chang TW; Quinter S; Hwang ST
    J Dermatol Sci; 2012 Jan; 65(1):4-11. PubMed ID: 22177422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
    Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
    Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology.
    Lee AYS; Körner H
    Immunobiology; 2019 May; 224(3):449-454. PubMed ID: 30772094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
    Wei W; Zhao X; Zhu J; Zhang L; Chen Y; Zhang B; Li Y; Wang M; Zhang Z; Wang C
    Oncol Rep; 2019 Nov; 42(5):1946-1956. PubMed ID: 31545478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
    Lu E; Su J; Zhou Y; Zhang C; Wang Y
    Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine CCL20 promotes the paclitaxel resistance of CD44
    Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
    Kirshberg S; Izhar U; Amir G; Demma J; Vernea F; Beider K; Shlomai Z; Wald H; Zamir G; Shapira OM; Peled A; Wald O
    PLoS One; 2011; 6(9):e24856. PubMed ID: 21949768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
    Qiu W; Wang G; Sun X; Ye J; Wei F; Shi X; Lv G
    Med Oncol; 2015 Mar; 32(3):75. PubMed ID: 25698534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-derived CCL20 affects B16 melanoma growth in mice.
    Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
    J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine receptor CCR6 expression in colorectal liver metastasis.
    Rubie C; Oliveira-Frick V; Rau B; Schilling M; Wagner M
    J Clin Oncol; 2006 Nov; 24(32):5173-4; author reply 5174. PubMed ID: 17093284
    [No Abstract]   [Full Text] [Related]  

  • 33. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
    Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of CCL20 reveals flexibility of N-terminal amino acid composition and length.
    Riutta SJ; Larsen O; Getschman AE; Rosenkilde MM; Hwang ST; Volkman BF
    J Leukoc Biol; 2018 Aug; 104(2):423-434. PubMed ID: 30114340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
    Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
    Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL
    J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells.
    Vongsa RA; Zimmerman NP; Dwinell MB
    J Biol Chem; 2009 Apr; 284(15):10034-45. PubMed ID: 19233848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.
    Liu B; Jia Y; Ma J; Wu S; Jiang H; Cao Y; Sun X; Yin X; Yan S; Shang M; Mao A
    Acta Biochim Biophys Sin (Shanghai); 2016 Dec; 48(12):1067-1074. PubMed ID: 27797715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
    Li Q; Laumonnier Y; Syrovets T; Simmet T
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.